Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Team from the Van den Eynde group have discovered that some molecules previously used to treat hypertension might also help the immune system to better fight cancer cells

Cancer immunotherapy is a treatment approach that helps T lymphocytes to destroy cancerous cells. Whilst this has allowed the treatment of some advanced cancers, it does not currently work in all patients or as effectively for all types of cancer.

New research by Jingjing Zhu and co-workers within the Van den Eynde team has led to the discovery of drugs once used to treat hypertension having an interesting effect in combating the immunotherapy-resistant cancers.

More information about these promising results can be found with the full paper published in Nature and comments from the authors can be seen via the press release at the Ludwig Institute for Cancer Research.

Similar stories

Ludwig Oxford at 2024 AACR

Ludwig Oxford staff and students alike share their research in San Diego at the 2024 AACR Annual Meeting